<DOC>
	<DOCNO>NCT01361984</DOCNO>
	<brief_summary>This PI-initiated study take place UCLA , sponsor Sunovion . The investigator plan enroll 20 subject least 40 year old Chronic Obstructive Pulmonary Disease ( COPD ) . The purpose study compare effectiveness Brovana Serevent help relieve COPD symptom . Specifically , investigator look much long two drug open small airway lung . This do breathing test subject , high resolution CT scan subject agree optional part study . Half subject take Brovana ( arformoterol tartrate inhalation solution ) 2 week Serevent ( salmeterol xinafoate inhalation powder ) 2 week ; half take Serevent first two week Brovana second two week . All subject also take Spiriva ( tiotropium ) provide albuterol immediate relief symptom . After Screening Visit determine eligibility , subject randomly assign receive Brovana Serevent first 2 week , complete Test Visit 1 , receive study drug 2 week , finally complete Test Visit 2 . Visits include questionnaire , review health medication , breathe test take study drug . Subjects agree sub-study also undergo CT scan take study drug test visit .</brief_summary>
	<brief_title>Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Age &gt; =40 year History smoking &gt; =20 packyears cigarette Be use medically acceptable birthcontrol measure female childbearing potential Be willing withhold exist short longacting bronchodilator appropriate time period prior test day . Use inhale corticosteroid exclusionary , maintain constant level throughout study . Must willing able perform spirometry , slow vital capacity , plethysmography , DLCO , 6 minute walk appropriate instruction . Informed consent At screen visit : Postalbuterol FEV1/FVC &lt; LLN ( Hankinson ) Postalbuterol FEV1 &lt; 70 % % &gt; =30 % predict ( Hankinson ) An increase FEV1 4 puff albuterol sulfate HFA least 5 % 50ml Presence clinically significant illness condition might interfere study , include limited uncontrolled hypertension , cardiovascular disease , cardiac arrhythmia , diabetes , hyperthyroidism , seizure disorder history pheochromocytoma History asthma ( opinion investigator ) A COPD exacerbation within past 2 month require oral corticosteroid hospitalization . Continuous oxygen therapy great 12 hour per day Subjects body mass index le 15 great 38 Known allergy contradiction albuterol , arformoterol , salmeterol , tiotropium prior significant adverse reaction beta agonist ipratropium . Hypersensitivity milk protein . Bloating gas lactose exclusion . Inability withhold adrenergic drug ( salmeterol , arformoterol , formoterol , albuterol etc . ) appropriate duration visit . Ongoing need drug might potentiate hypokalemia ( xanthine derivative ( theophylline ) , steroid , nonpotassium spar diuretic ( unless fix combination potassium spar diuretic ) Ongoing need drug might cause QTc prolongation ( MAO inhibitor , tricyclic antidepressant , cardiac antiarrhythmic Class Ia ( e.g. , disopyramide , procainamide , quinidine ) , class III ( e.g. , amiodarone , dofetilide , ibutilide , sotalol ) , terfenadine , astemizole , mizolastin drug potential significantly prolong QT interval . ) Ongoing need betablockers ( selective nonselective ) Use phenothizines ( thioridizine ) , drug may interact arformoterol , salmeterol albuterol duration study . Washout great seven halflives drug prior study . History angle closure glaucoma , symptomatic prostatic hypertrophy bladder neck obstruction . Investigational drug within 30 day Affiliation Division Pulmonary Critical Care Medicine , David Geffen School Medicine Pregnancy , breastfeeding , plan become pregnant study , woman childbearing potential unwilling use adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Emphysema</keyword>
	<keyword>Chronic Bronchitis</keyword>
	<keyword>Brovana</keyword>
	<keyword>Serevent</keyword>
</DOC>